Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge.

Geerts H, Dacks PA, Devanarayan V, Haas M, Khachaturian ZS, Gordon MF, Maudsley S, Romero K, Stephenson D; Brain Health Modeling Initiative (BHMI)..

Alzheimers Dement. 2016 Sep;12(9):1014-21. doi: 10.1016/j.jalz.2016.04.008. Review.

2.

Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?

Khachaturian ZS, Mesulam MM, Mohs RC, Khachaturian AS.

Alzheimers Dement. 2016 Mar;12(3):213-5. doi: 10.1016/j.jalz.2016.02.003. No abstract available.

PMID:
27012483
3.

The Special Topics Section of Alzheimer's & Dementia.

Khachaturian ZS, Mesulam MM, Khachaturian AS, Mohs RC.

Alzheimers Dement. 2015 Nov;11(11):1261-4. doi: 10.1016/j.jalz.2015.10.002. No abstract available.

PMID:
26589667
4.

Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease.

Orban P, Madjar C, Savard M, Dansereau C, Tam A, Das S, Evans AC, Rosa-Neto P, Breitner JC, Bellec P; PREVENT-AD Research Group..

Sci Data. 2015 Oct 13;2:150043. doi: 10.1038/sdata.2015.43.

5.

Massachusetts Alzheimer's Disease Research Center: progress and challenges.

Hyman BT, Growdon JH, Albers MW, Buckner RL, Chhatwal J, Gomez-Isla MT, Haass C, Hudry E, Jack CR Jr, Johnson KA, Khachaturian ZS, Kim DY, Martin JB, Nitsch RM, Rosen BR, Selkoe DJ, Sperling RA, St George-Hyslop P, Tanzi RE, Yap L, Young AB, Phelps CH, McCaffrey PG.

Alzheimers Dement. 2015 Oct;11(10):1241-5. doi: 10.1016/j.jalz.2015.06.1887. No abstract available.

6.

Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease.

Lista S, Khachaturian ZS, Rujescu D, Garaci F, Dubois B, Hampel H.

Methods Mol Biol. 2016;1303:49-67. doi: 10.1007/978-1-4939-2627-5_2. Review.

PMID:
26235059
7.

Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome.

Khachaturian ZS, Khachaturian AS.

Mol Aspects Med. 2015 Jun-Oct;43-44:3-15. doi: 10.1016/j.mam.2015.06.001. Review.

PMID:
26054567
8.

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.

Alzheimer's Association National Plan Milestone Workgroup., Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, Klunk W, Knopman D, Kukull WA, Lamb B, Logsdon RG, Maruff P, Mesulam M, Mobley W, Mohs R, Morgan D, Nixon RA, Paul S, Petersen R, Plassman B, Potter W, Reiman E, Reisberg B, Sano M, Schindler R, Schneider LS, Snyder PJ, Sperling RA, Yaffe K, Bain LJ, Thies WH, Carrillo MC.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S430-52. doi: 10.1016/j.jalz.2014.08.103.

9.

Perspective on the "2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease".

Khachaturian ZS.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S265-8. doi: 10.1016/j.jalz.2014.08.102. No abstract available.

PMID:
25341458
10.

Military risk factors for Alzheimer's dementia and neurodegenerative disease.

Khachaturian AS, Khachaturian ZS.

Alzheimers Dement. 2014 Jun;10(3 Suppl):S90-1. doi: 10.1016/j.jalz.2014.05.1085. No abstract available.

11.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Review.

PMID:
24275164
12.

Big data, aging, and dementia: pathways for international harmonization on data sharing.

Khachaturian AS, Meranus DH, Kukull WA, Khachaturian ZS.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S61-2. doi: 10.1016/j.jalz.2013.09.001. No abstract available.

13.

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Jackson G, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian ZS, Sutherland M, Abushakra S, Lewcock J, Farese R, Kenet RO, Laferla F, Perrin S, Whitaker S, Honig L, Mesulam MM, Boeve B, Grossman M, Miller BL, Cummings JL.

Alzheimers Dement. 2013 Mar;9(2):189-98. doi: 10.1016/j.jalz.2012.03.003. Review.

14.

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.

Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQ.

Alzheimers Dement. 2012 Sep;8(5):445-52. doi: 10.1016/j.jalz.2012.08.001.

15.

NAPA 2.0: the next giant leap.

Khachaturian AS, Paul SM, Khachaturian ZS.

Alzheimers Dement. 2012 Sep;8(5):379-80. doi: 10.1016/j.jalz.2012.08.002. No abstract available.

PMID:
22959697
16.

Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease.

Alzheimer's Association Expert Advisory Workgroup on NAPA..

Alzheimers Dement. 2012 Jul;8(4):357-71. doi: 10.1016/j.jalz.2012.04.003.

PMID:
22748940
17.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116. Review.

PMID:
22748938
18.

Biomarker development: a population-level perspective.

Khachaturian AS, Mielke MM, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):247-9. doi: 10.1016/j.jalz.2012.06.002. No abstract available.

PMID:
22748935
19.

The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).

Khachaturian ZS, Khachaturian AS, Thies W.

Alzheimers Dement. 2012 May;8(3):234-6. doi: 10.1016/j.jalz.2012.04.004.

PMID:
22546355
20.

Prospects for designating Alzheimer's disease research a national priority.

Khachaturian ZS.

Alzheimers Dement. 2011 Nov;7(6):557-61. doi: 10.1016/j.jalz.2011.10.001.

PMID:
22055971
Items per page

Supplemental Content

Loading ...
Support Center